Some 650,000 people are alive today who wouldn’t be were it not for advances in cancer prevention, detection and treatment over the past 15 years, new statistics show.
The American Cancer Society’s Cancer Statistics 2009 report finds an encouraging 19.2 percent drop in cancer death rates among men from 1990 to 2005, as well as [...]
Citalopram No Better Than Placebo Treatment for Children with Autism Spectrum Disorders
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published [...]
Doctors appear to have safely and successfully treated patients with cancer of the blood and bone marrow with a combination of arsenic and vitamin A, according to long-term study in China.
In an article published in the Proceedings of the National Academy of Sciences, the doctors said they prescribed the regimen to 85 patients and [...]
An article published in the B.C. Medical Journal has raised awareness again that children living near electrical power transmission lines run a slightly higher risk of succumbing to leukemia.
The article by Ray Copes, MD and Prabjit Barn, M.Sc. of the B.C. Centre for Disease Control was entitled, “Is living near power lines bad for our [...]
Children are facing an ‘explosion’ in obesity-related cancers thanks to junk food and a lack of exercise, an expert warned last night.
Professor Kathy Pritchard-Jones says thousands will die if parents and ministers do not take the childhood obesity epidemic more seriously.
Obesity is linked to cancers including those of the kidney, breast, colon, liver and prostate. [...]
Pharmaceutical company EpiCept Corp. (EPCT) said the U.S. FDA indicated that the company had necessary pivotal data to file a New Drug Application, or NDA, for Ceplene in combination with interleukin-2 as a remission maintenance treatment of acute myeloid leukemia.
The company noted that at a pre-NDA meeting last week, the U.S. regulatory body issued guidance [...]
Improved survival in chronic lymphocytic leukemia
Progression-free survival was improved in patients with chronic lymphocytic leukemia (CLL) who receive the combination of rituximab, fludarabine, and cyclophosphamide. Results of the phase III REACH study demonstrated a median improvement in progression-free survival of 10 months when compared with fludarabine and cyclophosphamide alone. In addition, complete response rates [...]
